INTERNATIONAL PATENT: IMMUNEERING CORPORATION FILES APPLICATION FOR "INHIBITING MITOGEN-ACTIVATED PROTEIN (MAP)/ERK KINASE (MEK)1 AND MEK2 AND RELATED METHODS OF TREATMENT"

GENEVA, March 19 -- IMMUNEERING CORPORATION (245 Main Street2nd FloorCambridge, Massachusetts 02142) filed a patent application (PCT/US2025/044738) for "INHIBITING MITOGEN-ACTIVATED PROTEIN (MAP)/ERK KINASE (MEK)1 AND MEK2 AND RELATED METHODS OF TREATMENT" on Sep 03, 2025. With publication no. WO/2026/055268, the details related to the patent application was published on Mar 12, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): HALL, Brett Matthew (245 Main Street2nd FloorCambridge, Massachusetts 02142), KING, Peter John (245 Main Street2nd FloorCambridge, Massachusetts 02142), NAIR, Praveen (...